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Despite some evidence of improved survival with intraoperative cholangiography (IOC) 
during cholecystectomy, debate has raged about its benefit, due in part to its questionable 




A PROSPERO-registered (ID CRD42018102154) meta-analysis following PRISMA 
guidelines using PubMed, Scopus, Web of Science and Cochrane library from 2003 to 2018 
was undertaken including search strategy “intraoperative AND cholangiogra* AND 
 
cholecystectomy”. Articles scoring ≥ 16 for comparative and ≥ 10 for non-comparative 
using the Methodological Index for Non-Randomised Studies (MINORS) criteria were 
included. A dichotomous random effects meta-analysis using the Mantel-Haenszel method 




Of 2,059 articles reviewed, 62 met criteria for final analysis. The mean rate of IOC was 38.8% 
(range 1.6-96.4%).There was greater detection of bile duct stones during cholecystectomy with 
routine IOC compared with selective IOC (OR= 3.28, CI= 2.80-3.86, p-value <0.001). While 
bile duct injury (BDI) during cholecystectomy was less with IOC (0.39%) than without IOC 
(0.43%), it wasn’t statistically significant (OR=0.88, CI=0.65- 
 
1.19, p-value= 0.41). Readmission following cholecystectomy with IOC was 3.0% 




The use of IOC still has its place in cholecystectomy based on the detection of 






common bile duct stones. This meta-analysis, the first to review IOC use, identified a marked 
variation in cholangiography use. Retrospective studies limit the ability to critically define 





































































26 There have been many paradigm shifts in cholecystectomy techniques since Carl Langenbuch 
 
27 reported the first cholecystectomy in 1882, and Mirizzi subsequently described 
 
28 cholangiography in 1932.1, 2 Coupled with this have been significant changes in the 
 
29 management of choledocholithiasis, suggesting an increased trend toward bile duct clearance 
 
30 intraoperatively.3, 4 In general, 3-12% of patients undergoing cholecystectomy have 
 
31 associated common bile duct stone,5, 6  and this is increased in those undergoing emergency 
 
32 surgery.7 The impact of common bile duct stones is not clearly understood, confounded by 
 
33 variable rates of stone passage and adverse sequelae.8, 9 It has been suggested that failure to 
 
34 remove CBD stones has an unfavourable outcome in 25%, which is halved by clearance of 
 
35 the CBD stone.8 
 
36 Elderly patients with untreated CBS stone have a higher incidence of gallstone related 
 
37 complications.10  Historically, surgeons have striven to detect common bile duct stone and 
 
38 anatomical abnormalities during cholecystectomy by using intraoperative cholangiography 
 
39 (IOC) as part of a perceived better surgical practice. Its use is decreasing,11 performed in a 
 
40 variable fashion from routinely to never. The reason for this variance probably relates to the 
 
41 time required, difficulty of the procedure, especially in acute cholecystitis, and having a clear 
 
42 algorithm for detected CBD stones. The value of IOC is certainly in question, spurred by 
 
43 improved pre-operative MRCP and widespread access to endoscopic ultrasound (EUS), 
 




46 The aim of the current meta-analysis was to evaluate the variability in performance and 
 









49 Materials and Methods 
 
 
50 Search strategy and study eligibility 
 
51 A meta-analysis of all published articles was conducted at Letterkenny University Hospital 
 
52 Ireland, in June 2018, using the electronic databases Pub Med, Scopus, Web of Science and 
 
53 the Cochrane Library for a 15 year period from January 2003 to June 2018. Additionally, a 
 
54 manual troll of trial registries and reference lists for grey literature was undertaken. The 
 
55 reproducible search strategy “intraoperative AND cholangiogra* AND cholecystectomy” was 
 
56 used across all four databases to include all relevant papers. 
 
 
57 Eligibility assessment and Data extraction 
 
58 The primary outcome was to assess the variability, and potential impact on surgical outcomes 
 
59 following the use intraoperative cholangiography during cholecystectomy. Secondary 
 
60 outcomes were to identify factors that contributed to any variability. 
 
 
61 The methods of analysis and inclusion criteria were specified in advance to avoid selection 
 
62 bias and documented in a protocol, registered with the International Prospective Register of 
 
63 Systematic Reviews (CRD42018102154) on the 23/07/2018. This meta-analysis adhered to 
 




66 Studies were included in the meta-analysis if the following criteria were met: either open or 
 
67 laparoscopic cholecystectomy, elective or emergency, where the use and findings of 
 
68 intraoperative cholangiography were reported and full articles were available in English. 
 
69 Studies based on paediatric or pregnant patients were not included. Reviews, meta-analyses, 
 
70 case reports, errata, letters, protocols, surveys, studies that did not report key outcomes, and 
 
71 those whose data was inadequate for interpretation via meta-analysis, were not included in 
 






73 Eligibility assessment was performed independently in a blinded standardised manner by two 
 
74 reviewers and disagreements between reviewers were resolved by discussion (ED, CM). 
 
 
75 The descriptive and quantitative data from the screened studies was extracted by two 
 
76 reviewers (ED, MC) and compared to ensure data extraction was complete. Data was 
 
77 collected using a data extraction sheet with pre-specified criteria, which were further refined 
 
78 after pilot testing of randomly chosen studies. 
 
 
79 Studies reporting the total number of cholecystectomies carried out with and without 
 
80 attempted IOC were analysed to assess the variability in IOC use across different studies. The 
 
81 mean rate of IOC was defined as the total number of successful cholangiographies completed 
 
82 as a percentage of the number of cholecystectomies carried out. As the use of IOC depends 
 
83 on the policy of a surgeon or hospital, randomized trials where participants were randomly 
 
84 allocated to treatment groups were not used in analysis of the rate of IOC use during 
 
85 cholecystectomy but were included for analysis of other outcomes. Studies that did not report 
 
86 the total number of cholecystectomies performed with IOC and without a planned IOC during 
 
87 the study period were also not used for the analysis of rate. 
 
 
88 Analysis of the rate under a selective and routine policy of IOC use was also carried out. An 
 
89 additional analysis of multi-centre studies (representing more than two institutions) only was 
 
90 performed to analyse the variation in the use of IOC across different countries, with studies 
 
91 from a same country grouped together. 
 
 
92 Data was extracted from studies that reported a routine or selective policy of IOC to evaluate 
 
93 the detection of common bile duct stones, incidence of bile duct injury, conversion rates and 
 
94 intraoperative complication rates under each policy. The rates of each outcome were 
 









96 The impact of intraoperative cholangiography on biliary injury and readmission rate was 
 
97 investigated by analysis of studies reporting outcomes with and without the use of 
 
98 intraoperative cholangiography. 
 
 
99 Quality assessment 
 
100 The Methodological Index for Non-Randomised Studies (MINORS) criteria,14 was used for 
 
101 quality assessment of comparative and non-comparative surgical studies using a 3-point scale 
 
102 (0 not reported, 1 reported but inadequate, 2 reported and adequate) on eight items for non- 
 
103 comparative studies and 12 items for comparative studies. The ideal global score for non- 
 
104 comparative and comparative studies was chosen at 16 and 24, respectively. All collated 
 
105 studies including randomised controlled trials were marked against the MINORS criteria to 
 
106 assess the studies with the best methodologies to include in the final analysis. Although the 
 
107 criteria were designed for non-randomised studies, randomised control trials were also 
 
108 marked using the criteria because they are the gold standard of original published research 
 
109 and were used in validating the MINORS criteria. Three reviewers performed quality 
 
110 assessment independently in a blinded standardised manner and disagreements between 
 
111 reviewers were resolved by discussion between the review authors (ED, MC, JC), and if an 
 
112 agreement could not be reached then by a fourth reviewer (LF). The studies with a MINORS 
 
113 score of ≥16 out of 24 for comparative and ≥10 out of 16 for non-comparative were included 
 
114 in the final analysis. 
 
 
115 Statistical Analysis 
 
116 A dichotomous meta-analysis using the Mantel-Haenszel method was used to analyse the 
 
117 data .15 The results were presented as pooled odds ratios with 95% confidence interval (CI) in 
 
118 a forest plot performed on Review Manager (RevMan) Version 5.3. Statistical significance 
 
119 was defined as p < 0.05. Statistical heterogeneity was measured using I2 scores calculated 
 





121 50%, otherwise a fixed effects model would be used. Any levels of substantial heterogeneity 
 
122 were explored in conjunction with the Cochrane Handbook for Systematic Reviews of 
 
123 Interventions Version 5.1.0 with an I2 statistic of 0%- 40% representing little heterogeneity 
 
124 between studies, 30%-60% moderate heterogeneity, 50%-90% substantial heterogeneity and 
 
125 75%-100% considerable heterogeneity.15 Chi-square testing was used to examine differences 
 





















































143 This study reviewed 2,059 articles of which 90 were potentially suitable. After applying the 
 
144 MINORS cut off score, 62 were included for meta-analysis as shown in the PRISMA flow 
 
145 chart, Figure 1. 
 
 
146 The rate of IOC use during cholecystectomy 
 
147 The rate of intraoperative cholangiography use during cholecystectomy was analysed across 
 
148 56 studies (n= 4,221,311). Six studies were not included because the total number of 
 
149 cholecystectomies with and without planned IOC was not reported, or the use of IOC was 
 
150 randomised to an intervention and control group. The mean rate of IOC use during 
 
151 cholecystectomy was 38.8% (range 1.6% to 96.4%). There was marked variation in the use of 
 
152 IOC with studies reporting data from 19 countries (Figure 2). The mean operating time for 
 
153 IOC across four studies was 11 minutes (range 6-15 min).16, 17, 18, 19 
 
154 When analysing 20 multicenter studies (96% of which were based on American and Swedish 
 
155 studies), the mean rate of IOC use was 38.5% (CI=38.5-38.6), range 12 to 88%. 6, 8, 11, 20-36 
 
156 The use of IOC from 11 multicenter studies carried out in the USA11, 20-29 revealed a mean 
 
157 rate of 33.2% (CI= 33.1-33.3) compared to a mean rate of 69.5% (CI= 69.4-69.6) from four 
 
158 multicenter Swedish studies.6, 8, 30, 31 
 
159 Comparing routine and selective policies of IOC 
 
160 A selective policy of IOC use was adopted in 14 studies with a mean IOC usage of 16.7% 
 
161 (2.8-36.9%) in 12,064 patients.18, 19, 34, 37-47 Additionally, 14 studies adopted a policy of 
 
162 routine IOC with a mean average usage of 88.3% (63.5-99.2%) in 25,072 patients.17, 19, 34, 37,  
163 42, 48-56 
 
 
164 Eleven studies (n=10,466) reported the incidence of common bile duct stones on routine IOC 
 





166 reported the incidence of common bile duct stones on selective IOC with a mean of 3.9%, 
 
167 range 0.7% to 12.8%.18, 19, 34, 37-39, 44, 45 A routine IOC policy significantly increased the rate of 
 
168 CBD stone detection (OR= 3.28, CI= 2.80-3.86, p-value <0.001). 
 
 
169 Five studies (n=116,726) 19, 34, 37, 38, 57 reported findings of bile duct injury from routine and 
 
170 selective policies of intraoperative cholangiography use (Figure 3). The average incidence of 
 
171 bile duct injury using a routine policy of IOC was 0.22%, compared with 0.27% for a 
 
172 selective approach (OR= 0.81, CI=0.57-1.15, p-value= 0.23). 
 
 
173 In 25 studies (n=71,191 patients) who reported successful IOC completion, the mean success 
 
174 rate was 95% (range 66% to 99%).5, 6, 16-19, 34, 37-44, 48-53, 55, 56, 59, 60 Successful completion of 
 
175 IOC was significantly greater with a routine IOC policy (95.2 %) compared to a selective 
 
176 policy (90.6%) (OR= 2.09, CI=1.73-2.51, p-value <0.001). 
 
 
177 Comparing bile duct injury and readmission rate with and without the use of IOC 
 
178 The incidence of bile duct injury during cholecystectomy with and without the use of IOC 
 
179 was assessed across 10 studies (n= 3,160,760 patients) as shown in Figure 4.6, 11,20, 21, 25, 30, 31, 
 
180 36, 61, 62 The total number of cholecystectomy patients with intraoperative cholangiography 
 
181 performed was 1,266,275 and the incidence of bile duct injury was 0.39%. The total number 
 
182 of patients undergoing cholecystectomy without cholangiography was 1,894,485 and the 
 
183 incidence of bile duct injury was 0.43%. Although IOC is potentially weakly associated with 
 
184 a lower incidence of bile duct injury, this effect is not significant (OR=0.88, CI=0.65-1.19, p- 
 
185 value= 0.41). There was also considerable heterogeneity reported (I2 = 97%). 
 
186 Four studies reported a readmission rate following cholecystectomy both with and without 
 
187 the use of intraoperative cholangiography (Figure 5). 11, 61, 28, 29 The total number of patients 
 
188 undergoing cholecystectomy with IOC was 105,908, with an average readmission rate of 
 






190 with an average readmission rate of 3.46%. IOC is not significantly associated with a 
 








































































194 This meta-analysis reviewed over 2000 publications identifying a wide variation in the 
 
195 performance of IOC, with variable detection of choledocholithiasis. Previously, there have 
 
196 been many studies of IOC but the current meta-analysis is one of the first to assess the impact 
 
197 of the variable use of IOC during cholecystectomy. 
 
 
198 Surgeons opting for the routine use of IOC feel it aids detection of common bile duct stones, 
 
199 and promotes surgical skills that facilitate cystic duct cannulation and transcystic single stage 
 
200 bile duct exploration, which is a safe and efficacious treatment option in the management of 
 
201 choledocholithiasis.63, 64 In addition, it has been suggested that IOC is an effective tool for 
 
202 effectively reducing bile duct injury but this has been the subject of major debate and the 
 
203 controversy remains.20, 27 With the advent of other imaging like ERCP and magnetic 
 
204 resonance cholangiopancreatography (MRCP),  the role of IOC has been challenged even 
 
205 further, with many surgeons opting for a selective policy of IOC use or not at all.46, 65 
 
206 Different approaches have been advocated in the management of CBD stones from 
 
207 laparoscopic single stage CBD clearance (LCBDC), to single and dual stage LCBDC with 
 
208 intra-operative ERCP.66, 67 In their meta-analysis, Pan and colleagues found that LCBDC 
 
209 during LC has superior outcomes to a pre-operative ERCP sphincterotomy followed by 
 
210 laparoscopic cholecystectomy (LC), and should be considered as optimal treatment choice for 
 
211 CBD stones.67 Mohseni et al, in a recent retrospective study of over 200 patients undergoing 
 




214 A key approach to single stage, or operative clearance, requires IOC to be performed even in 
 
215 cases with pre-operative MRCP. In a recent multicentre study of approaches to cholecystitis 
 






217 80% of the 25 centres reported that they favoured a staged approach with upfront ERCP 
 
218 followed by cholecystectomy (either during the same admission or, more commonly, at an 
 
219 interval). A minority of survey respondents favoured simultaneous cholecystectomy and 
 
220 either operative CBD exploration (4 of 25, 16%) or rendezvous intraoperative ERCP (5 of 25, 
 
221 20%) as a one-stage procedure.69 Our study identified that IOC was performed in over one 
 
222 third of patients (38.8%) undergoing cholecystectomy. This rate increased in Swedish and 
 
223 Australian cohorts compared to the US. In Australia, the Royal Australasian College of 
 
224 Surgeons report a 90% median use of IOC during cholecystectomy in their Surgical Variance 
 
225 Report 2017.70 A very recent multinational prospective evaluation of cholecystectomy 
 
226 outcomes in 504 patients in 16 countries found the IOC rate was 13% and pre-operative 
 
227 ERCP rate was 16%.71 These variations in IOC are truly remarkable, hard to explain 
 
228 scientifically and must in part be based on emotive learning by the surgeons involved. 
 
 
229 Surgical opinion regarding the appropriate indications for the selective use of IOC varied 
 
230 considerably, contributing to the range of selective IOC rates recorded (2.8-36.9%). Some 
 
231 studies reported high volume surgeons and high volume hospitals were more likely to 
 
232 perform IOC.21, 27, 35 Overall, this data was limited in the literature and not appropriate for 
 
233 statistical analysis. 
 
 
234 Selective IOC based on preoperative indications is supportive as an alternative to routine IOC 
 
235 for the detection of choledocholithiasis.39, 72 A selective policy of IOC use results in an IOC 
 
236 rate of 16.7% compared to 88.3% in the routine policy institutions. The success of routine 
 
237 IOC is limited by occluded, friable or very short cystic ducts, and the required lead lined 
 
238 operating rooms. 
 
 
239 The principal goal of IOC is CBD stone detection and this meta-analysis identified that 
 







241 an average incidence of CBD stones during routine IOC reported as 12% compared to 4% on 
 
242 selective IOC (OR= 3.28, CI= 2.80-3.86, p-value <0.001). Up to 50% of CBD stones will 
 
243 pass spontaneously and for this reason, some have argued for an expectant strategy based on 
 
244 spontaneous clearance rates of CBD stone.5, 73. The sequelae of persistent untreated stones are 
 
245 becoming clearer with an increase in adverse outcomes if the stones are not removed.10, 74 
 
246 However, these additional stones found on routine IOC may indeed be important, potentially 
 
247 causing further complications, recurrent cholangitis, pancreatitis and readmission, as well as 
 
248 possibly contributing to a post cholecystectomy syndrome.75, 76 Recently, Hakuta et al. 
 
249 revealed the cumulative incidence of biliary complications related to asymptomatic stones 
 
250 picked up on incidental imaging was 6.1% at 1 year, 11% at 3 years, and 17% at 5 years.9 
 
251 Möller et al., found that among patients in whom no measures taken intraoperatively or 
 
252 planned postoperatively (representing natural course), the risk for unfavourable outcomes 
 
253 ranged from 15.9% to 35.9% depending on stone size, in a cohort of patients diagnosed with 
 
254 CBD stones using IOC.8  Unfavourable outcome was defined as known incomplete clearance 
 
255 of bile ducts with any symptoms or complications related to bile duct stones within 30 days 
 
256 after cholecystectomy. This study also reported 14.9% of patients diagnosed with CBD stones 
 
257 using IOC required postoperative ERCP for CBD stone clearance. Their data from the 
 
258 Swedish GallRiks Registry is one of the largest analyses reported and provides a cautionary 
 





261 Many now feel that MRCP will replace the use of IOC, and almost one third of UK patients 
 
262 have a pre-operative MRI. This was a stimulus for the Sunflower study, assessing the clinical 
 
263 effectiveness and cost-effectiveness of an expectant management versus preoperative 
 
264 imaging with MRCP in patients with symptomatic gallstones undergoing laparoscopic 
 





266 has been shown previously to be an effective and safe strategy in the treatment of gallstones, 
 
267 with an acceptable rate of retained CBD stones and BDI.46 
 
268 In patients with gallstone pancreatitis, intraoperative imaging modalities such as IOC or 
 
269 laparoscopic ultrasound (LUS) are important in ensuring that patients are not at risk of 
 
270 subsequent pancreatitis due to retained CBD stones.78 The main benefit of IOC and LUS over 
 
271 MRCP is its ability to enable CBD imaging at the time of laparoscopic cholecystectomy. IOC 
 
272 has been reported to exhibit a higher diagnostic accuracy at detecting choledocholithiasis 
 
273 compared with MRCP (98% vs. 85),79  while Richard et al. concluded that there was no place 
 
274 for preoperative MRCP in patients with suspected choledocholithiasis due to the 
 
275 unacceptably elevated rate of false negative results compared with IOC.80 Thacoor et al. 
 
276 similarly concluded that patients presenting with acute gallstone pancreatitis can be safely 
 
277 and successfully managed with laparoscopic cholecystectomy and IOC, without requiring a 
 
278 preoperative MRCP.81 
 
279 In a randomised controlled trial, Lehrskov found fluorescent cholangiography was not 
 
280 inferior to IOC in detecting the cystic junction with the CBD. This study was very selective 
 
281 including 120 of a potential cohort of 1889 patients with 60 in each arm in a single surgeon 
 
282 study over three years.12 
 
283 The role of laparoscopic ultrasound (LUS) in identifying biliary anatomy and preventing 
 
284 CBD injury is not well defined. LUS and IOC have similar success in visualising the biliary 
 
285 anatomy but it is not widely available and requires significant experience. 82, 83 
 
286 There is evidence to support the routine use of IOC in the prevention, diagnosis and 
 
287 management of bile duct injury.17, 34, 84 During the transitioning period from open to 
 
288 laparoscopic cholecystectomy, a previous meta-analysis conveyed the effective role of 
 






290 cholecystectomy has changed with the introduction of the critical view of safety technique. It 
 
291 is has been suggested that implementation of a critical view of safety (CVS) could replace 
 
292 routine IOC, but this may reduce the detection rate of choledocholithiasis.45 In many cases of 
 
293 severe cholecystitis the CVS is not visible, and IOC may be difficult in those patients. In their 
 
294 retrospective study, 57/477 had IOC, and 15/57 had choledocholithiasis. One must assume 
 
295 therefore that the incidence of missed CBD stones must have been significant. Other authors 
 
296 have argued that the two together provide optimal patient outcome.38 In a recent consensus 
 
297 conference on prevention of bile duct injury during cholecystectomy, Brunt and colleagues 
 
298 recommended the use of IOC among surgeons to mitigate the risk of BDI.86 In our study, 
 
299 although routine IOC was shown to reduce bile duct injury in the majority of studies, it was 
 
300 an insignificant association. The definition of BDI in these included studies was lacking. For 
 
301 example, Törnqvist includes all forms of bile leakage and cystic duct leakage post 
 
302 cholecystectomy when reporting BDI rate of over 1.3%.6 
 
303 Bile duct injury occurs in 0.3% of cholecystectomies, which results in 2500 injuries per 
 
304 annum in the US alone, with resultant 8.8-fold increase in mortality and a common cause for 
 
305 litigation. 87, 88 The numbers to power a RCT to finally answer the question whether IOC 
 
306 reduces the rate of BDI at cholecystectomy would be near impossible.89 For this reason, the 
 
307 best available evidence comes from large-scale retrospective analyses. However, these 
 
308 analyses are limited in their interpretation. Three retrospective studies reporting the smallest 
 
309 percentage use of IOC during cholecystectomy are also the three studies reporting an 
 
310 association of increased BDI with IOC.11, 25, 36 The recent recommendation by the Prevention 
 
311 of Bile Duct Injury Consensus Work Group, for the liberal use of IOC in acute hot 
 
312 gallbladder surgery could skew a potential association of IOC with a higher incidence of BDI 
 








314 after an injury has occurred makes the interpretation of the value of IOC uncertain on 
 
315 retrospective analysis. 
 
 
316 This meta-analysis was hampered by considerable statistical heterogeneity reported in the 
 
317 analysis of bile duct injury (p-value< 0.0001, I2 =97%) and readmission rate (p-value< 
 
318 0.0001, I2 =88%) (Figure 4 and 5). Clinical diversity relating to the differences associated 
 
319 with the participants, interventions and outcomes, as well as methodological diversity, 
 
320 contribute to the statistical heterogeneity reported. Furthermore, IOC use extended widely, 
 
321 from routine, selective, to no use at all. A subgroup analysis of the three more routine policies 
 
322 allowed a reduction of I2 statistic to 64%, with all three reporting a significant protective 
 
323 effect. 6, 30, 31 The remaining five retrospective studies adopting a more selective IOC use, 
 
324 reported an I2 statistic of 99% when grouped together, revealing an inconclusive effect of the 
 
325 relationship of IOC and BDI. 11, 20, 21, 61, 62 Further investigation of the participants analysed in 
 
326 each of these studies revealed a difference in the average age, with two studies reporting 
 
327 outcomes only from patients aged above 66 and differences involving the indication for 
 
328 cholecystectomy. 21, 25 Of the 10 studies analysed, two were prospective randomized trials 
 
329 reporting outcomes from a small number of patients and therefore a much smaller number of 
 
330 events 61, 62 while the remaining 8 were large retrospective studies using regional or national 
 
331 databases of registered cholecystectomies.6, 11, 20, 21, 25, 30, 31, 36 
 
332 Recent new practice guidelines aimed at prevention of CBD injury make reference to an 
 
333 unpublished meta-analsyis of 8 studies showing the use of IOC was associated with 
 
334 increased intraoperative recognition of CBD injury compared to those without IOC (OR 2.92, 
 
335 95% CI 1.55-5.68, p=0.014). 86 
 
336 Readmission rate assessed across four studies revealed an insignificant association, with IOC 
 







338 analysis on readmission rate following LC, suggested that IOC might reduce readmission 
 
339 rate.90 The differences in study design explain part of heterogeneity represented. However, 
 
340 differences in the clinical definition of readmission also existed. Readmission rate was 
 
341 defined according to 30 days11, 28, 29 or one year.61 The readmissions were defined in most 
 
342 cases as any referral or readmission to a hospital or clinic, whether they were related to the 
 
343 primary operation or not, usually not defined. One author appropriately defined readmission 
 
344 as being related to the primary operation however, which is a more accurate definition but 
 
345 likely to record a smaller number of events.28 
 
346 There were some limitations to our study due to a lack of reported data on intra-operative 
 
347 complication and conversion rates related to both routine and selective policies of IOC and 
 
348 use of papers in English only. This meta- analysis was not tasked with assessment of the 
 
349 actual skill set required to undertake IOC and its potential benefit in facilitating transcystic 
 
350 CBD stone clearance. 
 
 
351 Where routine IOC is planned, the success of the procedure is high (95%) and with a short 
 
352 time to complete (11 min). An important aspect of IOC is the ability of the general surgeon to 
 
353 interpret the results. Interpretation of anatomy was recently described in a study by Chehade 
 
354 that reported 95% of IOCs adequately demonstrated biliary anatomy. Aberrant right sectoral 
 
355 ducts were identified in 15.2% of the complete IOCs, and 2.6% demonstrated left sectoral or 
 
356 confluence anomalies. Only 20.4% of these were reported intraoperatively. 91  Regarding the 
 
357 detection of CBD stones, the combined sensitivity and specificity of IOC in the detection of 
 
358 CBD stones is reported as 0.87 (95% CI: 0.83–0.89) and 0.98 (95% CI: 0.98–0.98) 
 
359 respectively. 78 
 
360 We believe that IOC has benefits even in an era of increasing availability of MRCP. Other 
 







362 effectiveness of LCBDE- LC varies between studies, with a recent series by Ballou et al. 
 
363 reporting a success rate of completion and stone clearance of 66%,92 while others have 
 
364 reported success rates of 80-98.5%.93-95 With increasing use of one stage bile duct clearance, 
 
365 either with or without intra-operative ERCP, ability to cannulate the cystic duct is becoming 
 
























































384 The use of IOC still has its place in cholecystectomy based on the detection of 
 
385 choledocholithiasis, and the potential reduction of unfavourable outcomes associated with 
 































































389 Figure 1: Identification, review and selection of articles included in the meta-analysis, shown  
390 by PRISMA Flow Chart 
 
391                       
I d e n t i f i c a t i o n 
Records identified through   Additional records identified  
database search    through other sources  
     
392 (n= 2,055)      (n = 4)   
393 
           
           
394 
           
 Records after duplicates removed       
    (n = 1,053)      
395                       
S c r e e n i n g             
396   
Records screened 
   
Records excluded       
    (n = 1,053)    (n = 780) 
397                       
398 
           
           
         
Full-text articles 
          
E l i g i b i l i t y 
   Full-text articles          excluded, with   
assessed for eligibility 
 
399       reasons     (n = 273)           (n =183)           
400 
           
           
            
 
Studies included in 
401
 qualitative synthesis 
(n = 90)   
402   
I n c l u d e d  
 
Studies included in 403 
quantitative synthesis  
 (meta-analysis) 
















































































































































































































































































































































































































































429 Figure 3: The rate of biliary injury during cholecystectomy with routine IOC versus selective  
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Table 1. Characteristics of studies reporting outcomes from a routine or selective policy of 
IOC use 
 
Study ID Year Study design Study Policy of IOC Incidence of Incidence of bile 
   Period  common bile duct duct injury with 
     stones detected by routine and 
     IOC selective IOC 
       
Amott et al. 2005 Prospective randomized 1995-2002 Routine and Routine: 8.1% Routine: 0.68% 
  study  selective Selective: 3.2% Selective: 0.65% 
Wu et al. 2005 Prospective study 1988-2000 Selective 9.2% - 
       
Nickkholgh et al. 2006 Retrospective study 1992-2001 Routine and Routine:2.8% Routine:0% 
    Selective Selective:1.1% Selective: 0.25% 
Horwood et al. 2010 Prospective study 2004-2008 Selective 12.8% - 
       
Sanjay et al. 2010 Retrospective study 2004-2007 Selective 3.4% - 
       
Alkhaffaf et al. 2011 Comparison study using 2005-2007 Routine and Routine:7.8% Routine: 0% 
  data collected from a  selective Selective: 0.7% Selective: 0.35% 
  prospective database.     
       
Buddingh et al. 2011 Retrospective study 2004-2009 Routine and Routine: 4.8% Routine:0% 
    selective Selective:1.0% Selective:1.9% 
Giulea et al. 2016 Retrospective study 2013-2014 Selective 6.1% - 
       
Nassar et al. 2015 Prospective study 1992-2014 Routine 18.9% - 
       
Photi et al. 2017 Retrospective study 2013-2015 Routine 10.1% - 
       
Tan et al. 2006 Prospective study 2004 Routine 5.9% - 
       
Videhult et al. 2008 Prospective study 2003-2005 Routine 11.4% - 
       
Ragulin-Coyne et al. 2012 Retrospective study 2004-2009 Routine and - Routine:0.25% 
    Selective  Selective:0.26% 
       
Sheen et al. 2007 Prospective study 1999-2006 Routine 7% - 
       
Iranmanesh et al. 2018 Retrospective study of a 2013-2015 Routine 6.6% - 
  prospective database     
       
Yeo et al. 2011 Prospective study 2009-2010 Routine 9.1% - 




Table 2. Characteristics of studies reporting outcomes with and without the use of IOC 
 
Study ID Year Study design Study Use of IOC Incidence of BDI with Readmission rate 
 Published  period  and without IOC with and without 
      IOC 
       
Altieri et al. 2018 Retrospective analysis 2000-2014 11.7% With: 0.25% With: 4.5% 
     Without: 0.12% Without: 4.3% 
Ding et al. 2015 Randomized trial 2012-2014 Patients equally randomized to With: 0.54% - 
    2 treatment groups: LC and Without:0.54%  
    IOC, Routine LC.   
Flum et al. 2003 Retrospective study 1992-1999 39.1% With: 0.39% - 
     Without:0.58%  
Giger et al. 2011 Retrospective analysis of 1995-2005 36.6% With:0.34% - 
  a prospectively collected   Without:0.3%  
  database     
       
Khan et al. 2011 Randomized trial 2003-2007 Patients equally randomized to With: 0% With: 0% 
    2 treatment groups: LC with Without: 1% Without: 4% 
    IOC, LC only   
Halawani et al. 2016 Retrospective study 2012-2013 21.3% - With: 2.2% 
      Without: 2.7% 
Lilley et al. 2017 Retrospective study 2005-2010 35% With: 0.39% - 
     Without: 0.26%  
Rosero et al. 2017 Retrospective study 2009-2011 21.1% - With:1.8% 
      Without: 2.1% 
Sheffield et al. 2013 Retrospective study 2001-2009 40.4% With:0.21% - 
     Without:0.36%  
Törnqvist et al. 2009 Retrospective study 1965-2005 68.6% With: 0.3% - 
     Without:0.52%  
Törnqvist et al. 2015 Retrospective study 2005-2010 83.6% With:1.37% - 
     Without:1.97%  
Waage et al. 2006 Retrospective study 1987-2001 62.1% With: 0.35% - 
     Without: 0.48%  
       
LC- laparoscopic cholecystectomy      
